Perinatal Generalized Anxiety Disorder: Assessment and Treatment
- 1 September 2015
- journal article
- Published by Mary Ann Liebert Inc in Journal of Women's Health
- Vol. 24 (9), 762-770
- https://doi.org/10.1089/jwh.2014.5150
Abstract
Perinatal generalized anxiety disorder (GAD) has a high prevalence of 8.5%-10.5% during pregnancy and 4.4%-10.8% postpartum. Despite its attendant dysfunction in the patient, this potentially debilitating mental health condition is often underdiagnosed. This overview will provide guidance for clinicians in making timely diagnosis and managing symptoms appropriately. A significant barrier to the diagnosis of GAD in the perinatal population is difficulty in distinguishing normal versus pathological worry. Because a perinatal-specific screening tool for GAD is nonexistent, early identification, diagnosis and treatment is often compromised. The resultant maternal dysfunction can potentially impact mother-infant bonding and influence neurodevelopmental outcomes in the children. Comorbid occurrence of GAD and major depressive disorder changes the illness course and its treatment outcome. Psychoeducation is a key component in overcoming denial/stigma and facilitating successful intervention. Treatment strategies are contingent upon illness severity. Cognitive behavior therapy (CBT), relaxation, and mindfulness therapy are indicated for mild GAD. Moderate/severe illness requires pharmacotherapy and CBT, individually or in combination. No psychotropic medications are approved by the FDA or Health Canada in pregnancy or the postpartum; off-label pharmacological treatment is instituted only if the benefit of therapy outweighs its risk. SSRIs/SNRIs are the first-line treatment for anxiety disorders due to data supporting their efficacy and overall favorable side effect profile. Benzodiazepines are an option for short-term treatment. While research on atypical antipsychotics is evolving, some can be considered for severe manifestations where the response to antidepressants or benzodiazepines has been insufficient. A case example will illustrate the onset, clinical course, and treatment strategies of GAD through pregnancy and the postpartum.Keywords
This publication has 98 references indexed in Scilit:
- POSTPARTUM GAD IS A RISK FACTOR FOR POSTPARTUM MDD: THE COURSE AND LONGITUDINAL RELATIONSHIPS OF POSTPARTUM GAD AND MDDDepression and Anxiety, 2013
- Maternal cognitions and mother–infant interaction in postnatal depression and generalized anxiety disorder.Journal of Abnormal Psychology, 2012
- Maternal cortisol over the course of pregnancy and subsequent child amygdala and hippocampus volumes and affective problemsProceedings of the National Academy of Sciences of the United States of America, 2012
- The effects of postnatal maternal depression and anxiety on the processing of infant facesJournal of Affective Disorders, 2011
- Generalized anxiety disorder: Course and risk factors in pregnancyJournal of Affective Disorders, 2011
- Fetal growth and the lifetime risk of generalized anxiety disorderDepression and Anxiety, 2010
- Psychoeducation for depression, anxiety and psychological distress: a meta-analysisBMC Medicine, 2009
- Mindfulness-Based Childbirth and Parenting Education: Promoting Family Mindfulness During the Perinatal PeriodJournal of Child and Family Studies, 2009
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of Internal Medicine, 2006
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983